Par Drugs IPO Details

Issue Open May 3, 2019
Issue Close May 8, 2019
IPO Price ₹51
Face Value ₹10
IPO Size ₹8.53 Cr
Listing At NSE SME
IPO Lot Size 2000
  1. Re­cur­sion lays out $300M+ goal in IPO terms; Evotec and Bris­tol My­ers team up to spin out Ger­man re­search

    Mon, 12 Apr 2021 03:00:00 GMT

    Recursion is nearly ready to make its public debut, and the biotech set out what the potential raise might look like Monday. Recursion set its IPO terms, planning to raise $306 million by offering ...

  2. Coinbase CEOs net worth soars to $20billion thanks to company IPO

    Wed, 14 Apr 2021 04:34:50 GMT

    Wall Street will be focused on Coinbase Wednesday with the digital currency exchange becoming a publicly traded company. Coinbase is making its ...

  3. MPM-backed Were­wolf, Mer­ck-part­nered Arti­va make quick IPO flip while Lu­ca Santarel­lis biotech rais­es $127.5M

    Fri, 09 Apr 2021 03:28:00 GMT

    While Vec­tivBio is look­ing to in-li­cense or ac­quire ad­di­tion­al drugs for the pipeline, the IPO pro­ceeds are ... early data that looks pretty par for the course.

  4. These 5 Hot IPOs Post Weak Q4 Results

    Thu, 01 Apr 2021 19:07:00 GMT

    The average IPO in 2020 was $353 million ... Unfortunately, this is par for the course for PLTR, as the company has yet to turn a profit in its 17 years of existence. The stock hit a high of ...

  5. Small Cap Wrap - MAST Energy Developments, Imperial X, NextEnergy Renewables and more...

    Mon, 12 Apr 2021 06:46:00 GMT

    What’s cooking in the IPO ... Drug Discovery company, today announces that its subsidiary, C4X Discovery Limited, has signed an exclusive worldwide licensing agreement with Sanofi (NASD: SNY ...

  6. Coinbase is here: A digital currency exchange goes public

    Wed, 14 Apr 2021 09:44:00 GMT

    Wall Street will be focused on Coinbase on Wednesday with the digital currency exchange becoming a publicly traded company. The opening price of a share is expected to be around $340 and could ...

  7. Tencent-backed Waterdrop faces pushback on IPO from Chinese regulators - sources

    Tue, 13 Apr 2021 00:39:00 GMT

    The China Banking and Insurance Regulatory Commission (CBIRC), however, has questioned the company's business risks, which has slowed down the IPO process, they said. CBIRC even told founder Shen Peng ...

  8. UPDATE 1-Chinas revamp of Ant dents investor appetite for IPO revival

    Mon, 12 Apr 2021 23:59:00 GMT

    Last year, Ant's valuation was touted at $315 billion for its IPO, which was pulled just before its November listing in Shanghai and Hong Kong. Even before news of the revamp, sources told Reuters ...

  9. Exclusive: Brazilian payments network Elo picks banks for IPO - sources

    Thu, 08 Apr 2021 09:17:00 GMT

    The payments network - launched a decade ago to compete with Visa Inc and Mastercard Inc - is planning an IPO on Nasdaq, the sources said, following recent successful listings by Brazilian financial ...

  10. Universe Pharmaceuticals INC (UPC)

    Thu, 25 Mar 2021 09:36:00 GMT

    Universe Pharmaceuticals INC (the “Company”) closed its initial public offering (“IPO”) of 5,000,000 ordinary shares, par value $0.003125 per share (the “Ordinary Shares”). The ...

Par Drugs IPO Alerts

1. Par Drugs IPO Allotment Status  Tuesday, May 14, 2019 12:44:15 AM

The allotment status of Par Drugs and Chemicals Limited IPO is now available online. The public issue of Par Drugs IPO was open on May 3, 2019 and closed for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

2. Par Drugs IPO Listing Date & Info  Monday, May 13, 2019 11:18:15 PM

The IPO Shares of Par Drugs and Chemicals Limited IPO are proposed to list on Thursday, May 16, 2019 at NSE SME. The public issue of Par Drugs IPO was opened on May 3, 2019 and closed for subscription on May 8, 2019. Par Drugs IPO Listing Date and Information:

  • Listing Date: Thursday, May 16, 2019
  • BSE Script Code:
  • NSE Symbol: PAR
  • Listing In:
  • ISIN:
  • Issue Price: 51
  • Face Value: Rs 10 Per Equity Share

3. par drugs ipo Opens on May 3, 2019  Friday, April 26, 2019 10:48:34 AM

Par Drugs and Chemicals Limited is entering in the capital market with an IPO of 1,700,000 Equity Shares of Rs 10 aggregating up to Rs 8.53 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules which are in great demand in the market.

The issue opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

4. par drugs ipo Closes on May 8, 2019  Friday, April 26, 2019 10:48:34 AM

The issue of Par Drugs and Chemicals Limited opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

Par Drugs IPO News & Events FAQs

  1. 1. When Par Drugs IPO expected date?

    The Par Drugs IPO is proposed to open on May 3, 2019. The IPO application ends on May 8, 2019.

  2. 2. How to purchase Par Drugs IPO?

    Retail investors can apply in the retail or non-institutional investor category from May 3, 2019 to May 8, 2019. The Par Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Par Drugs IPO will come?

    The Par Drugs IPO will open for subscription on May 3, 2019. The public issue will close on May 8, 2019.


Comments

Add a public comment...








Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App